You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 16, Issue 21

November-1 2024 - 165 articles

Cover Story: Improving knowledge in AML immunobiology may translate to better clinical developments in immunotherapies for patients with AML. Harnessing the immune system against leukemia cells can be a powerful treatment strategy for AML patients. Immune-based therapies such as BiTE and CAR-T cell therapy have proven to be effective means of targeting chemotherapy resistance in AML, but their therapeutic benefits are not durable and limited only to a fraction of patients. However, despite these limitations, recent studies have shown the peculiar sensitivity of some AML subtypes to immunotherapy, such as multiplex antigen targeting, and have provided the basis for future studies, thus holding the promise of successful clinical developments. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (165)

  • Article
  • Open Access
3 Citations
2,065 Views
20 Pages

MiRNA Profiling of Areca Nut-Induced Carcinogenesis in Head and Neck Cancer

  • Hung-Han Huang,
  • Joseph T. Chang,
  • Guo-Rung You,
  • Yu-Fang Fu,
  • Eric Yi-Liang Shen,
  • Yi-Fang Huang,
  • Chia-Rui Shen and
  • Ann-Joy Cheng

3 November 2024

Background: While miRNAs are increasingly recognized for their role in tumorigenesis, their involvement in head and neck cancer (HNC) remains insufficiently explored. Additionally, the carcinogenic mechanisms of areca nut, a major habitual carcinogen...

  • Article
  • Open Access
3 Citations
5,180 Views
20 Pages

Predictors and Profile of Severe Infectious Complications in Multiple Myeloma Patients Treated with Daratumumab-Based Regimens: A Machine Learning Model for Pneumonia Risk

  • Damian Mikulski,
  • Marcin Kamil Kędzior,
  • Grzegorz Mirocha,
  • Katarzyna Jerzmanowska-Piechota,
  • Żaneta Witas,
  • Łukasz Woźniak,
  • Magdalena Pawlak,
  • Kacper Kościelny,
  • Michał Kośny and
  • Paweł Robak
  • + 4 authors

3 November 2024

Background: Daratumumab (Dara) is the first monoclonal antibody introduced into clinical practice to treat multiple myeloma (MM). It currently forms the backbone of therapy regimens in both newly diagnosed (ND) and relapsed/refractory (RR) patients....

  • Article
  • Open Access
1 Citations
1,661 Views
9 Pages

The Role of Bladder-Washing Cytology as an Adjunctive Method to Cystoscopy During Follow-Up for Low-Grade TaT1 Non-Muscle-Invasive Bladder Cancer

  • Enric Carbonell,
  • Clàudia Mercader,
  • Héctor Alfambra,
  • Paulette Narvaez,
  • Eric Villalba,
  • Rita Pagès,
  • Ignacio Asiain,
  • Meritxell Costa,
  • Agustín Franco and
  • Antonio Alcaraz
  • + 2 authors

1 November 2024

Background and Objective: The role of urine cytology during follow-up for low-grade (LG) non-muscle-invasive bladder cancer (NMIBC) is not well established, although cytology has low sensitivity in detecting LG recurrences. Our study aims to evaluate...

  • Article
  • Open Access
1,695 Views
16 Pages

The Influence of the Microbiome on the Complications of Radiotherapy and Its Effectiveness in Patients with Laryngeal Cancer

  • Karolina Dorobisz,
  • Tadeusz Dorobisz,
  • Katarzyna Pazdro-Zastawny,
  • Katarzyna Czyż and
  • Marzena Janczak

1 November 2024

Introduction: Radiotherapy is an effective method of treating cancer and affects 50% of patients. Intensity-modulated radiotherapy (IMRT) is a modernized method of classical radiation used in the treatment of laryngeal cancer. Treatment with intent t...

  • Review
  • Open Access
10 Citations
6,285 Views
31 Pages

1 November 2024

Background: Recent research underscores a crucial connection between circadian rhythm disruption and cancer promotion, highlighting an urgent need for attention. Objectives: Explore the molecular mechanisms by which modern lifestyle factors—suc...

  • Article
  • Open Access
5 Citations
3,019 Views
17 Pages

TGF-β Signaling Loop in Pancreatic Ductal Adenocarcinoma Activates Fibroblasts and Increases Tumor Cell Aggressiveness

  • Noemi di Miceli,
  • Chiara Baioni,
  • Linda Barbieri,
  • Davide Danielli,
  • Emiliano Sala,
  • Lucia Salvioni,
  • Stefania Garbujo,
  • Miriam Colombo,
  • Davide Prosperi and
  • Metello Innocenti
  • + 1 author

1 November 2024

Background: The interaction between cancer cells and cancer-associated fibroblasts (CAFs) is a key determinant of the rapid progression, high invasiveness, and chemoresistance of aggressive desmoplastic cancers such as pancreatic ductal adenocarcinom...

  • Correction
  • Open Access
1,001 Views
2 Pages

Correction: Lepore Signorile et al. c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer. Cancers 2022, 14, 4840

  • Martina Lepore Signorile,
  • Valentina Grossi,
  • Candida Fasano,
  • Giovanna Forte,
  • Vittoria Disciglio,
  • Paola Sanese,
  • Katia De Marco,
  • Francesca La Rocca,
  • Raffaele Armentano and
  • Anna Maria Valentini
  • + 2 authors

1 November 2024

In the original publication [...]

  • Review
  • Open Access
64 Citations
31,477 Views
55 Pages

Microplastics in the Human Body: Exposure, Detection, and Risk of Carcinogenesis: A State-of-the-Art Review

  • Eliasz Dzierżyński,
  • Piotr J. Gawlik,
  • Damian Puźniak,
  • Wojciech Flieger,
  • Katarzyna Jóźwik,
  • Grzegorz Teresiński,
  • Alicja Forma,
  • Paulina Wdowiak,
  • Jacek Baj and
  • Jolanta Flieger

1 November 2024

Background: Humans cannot avoid plastic exposure due to its ubiquitous presence in the natural environment. The waste generated is poorly biodegradable and exists in the form of MPs, which can enter the human body primarily through the digestive trac...

  • Review
  • Open Access
24 Citations
14,752 Views
23 Pages

The Evolution of Artificial Intelligence in Medical Imaging: From Computer Science to Machine and Deep Learning

  • Michele Avanzo,
  • Joseph Stancanello,
  • Giovanni Pirrone,
  • Annalisa Drigo and
  • Alessandra Retico

1 November 2024

Artificial intelligence (AI), the wide spectrum of technologies aiming to give machines or computers the ability to perform human-like cognitive functions, began in the 1940s with the first abstract models of intelligent machines. Soon after, in the...

  • Article
  • Open Access
4 Citations
2,219 Views
25 Pages

TRBP2, a Major Component of the RNAi Machinery, Is Subjected to Cell Cycle-Dependent Regulation in Human Cancer Cells of Diverse Tissue Origin

  • Eleni I. Theotoki,
  • Panos Kakoulidis,
  • Athanassios D. Velentzas,
  • Konstantinos-Stylianos Nikolakopoulos,
  • Nikolaos V. Angelis,
  • Ourania E. Tsitsilonis,
  • Ema Anastasiadou and
  • Dimitrios J. Stravopodis

1 November 2024

Background: Transactivation Response Element RNA-binding Protein (TRBP2) is a double-stranded RNA-binding protein widely known for its critical contribution to RNA interference (RNAi), a conserved mechanism of gene-expression regulation mediated thro...

of 17

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694